Additionally, O304 preserved β-cell function in an insulin resistant, hyperglycemic context in vivo and prevented, and reverted, the negative effects of chronic hyperglycemia on β-cell function/GSIS in vitro, at least in part by antagonizing mTORC1 signalling. The gene discussed is INS; the disease is Hyperglycemia.